Vertex Pharma poised to dominate global gene therapy market with first CRISPR approval: GlobalData Read more
Verve’s gene-editing therapy trial to lower cholesterol levels opens doors for use in CVDs: GlobalData Read more
Tel Aviv University develops novel lipid nanoparticle-based delivery system to destroy cancer cells Read more